BI 836880
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for BI 836880, covering 2024-11-20 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer [Phase 1]